Psychopharmacology of Williams syndrome: safety, tolerability, and effectiveness

References

• Strømme P, Bjømstad PG, Ramstad K. Prevalence estimation of Williams syndrome. J Child Neurol. 2002;17:269–271.
   PubMed Web of Science ®Google Scholar
• Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5:11–16.
   PubMed Web of Science ®Google Scholar
• Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362:239–252.
   PubMed Web of Science ®Google Scholar
• Morris CA, Braddock SR, Chen E, et al. Health care supervision for children with Williams syndrome. Pediatrics. 2020;145:e20193761.
   Web of Science ®Google Scholar
• Bellugi U, Lichtenberger L, Jones W, et al. The neurocognitive profile of Williams syndrome: A complex pattern of strengths and weaknesses. J Cogn Neurosci. 2000;12:7–29.
   PubMed Web of Science ®Google Scholar
• Morris CA. The behavioral phenotype of Williams syndrome: A recognizable pattern of neurodevelopment. Am J Med Genet C Semin Med Genet. 2010;154C:427–431.
   PubMed Web of Science ®Google Scholar
• Mervis CB, John AE. Cognitive and behavioral characteristics of children with Williams syndrome: implications for intervention approaches. Am J Med Genet C Semin Med Genet. 2010;154:229–248.
   Google Scholar
• Ng R, Järvinen A, Bellugi U. Toward a deeper characterization of the social phenotype of Williams syndrome: the association between personality and social drive. Res Dev Disabil. 2014;35:1838–1849.
   PubMed Web of Science ®Google Scholar
• Klein-Tasman BP, Li-Barber KT, Magargee ET. Honing in on the social phenotype in Williams syndrome using multiple measures and multiple raters. J Autism Dev Disord. 2011;41:341–351.
   PubMed Web of Science ®Google Scholar
• Gillooly AE, Riby DM, Durkin K, et al. Peer relationships in children with Williams syndrome: parent and teacher insights. J Autism Dev Disord. 2020. DOI:10.1007/s10803-020-04503-6.
   PubMed Web of Science ®Google Scholar
• Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, et al. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet Part B Neuropsychiatr Genet [Internet]. 2006;141B:615–622.
   PubMed Web of Science ®Google Scholar
• Green T, Avda S, Dotan I, et al. Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment. Am J Med Genet Part B Neuropsychiatr Genet. 2012;159B:13–20.
   PubMed Web of Science ®Google Scholar
• Jabbi M, Chen Q, Turner N, et al. Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli. Transl Psychiatry. 2015;5(8):e622-e622. .
   PubMedGoogle Scholar
• Pober BR, Morris CA. Diagnosis and management of medical problems in adults with Williams-Beuren syndrome. Am J Med Genet C Semin Med Genet. 2007;145:280–290.
   Google Scholar
• Abduljawad EM, AlHarthi A, AlMatrafi SA. et al. The prevalence of congenital heart diseases in syndromic children at King Khalid National Guard Hospital from 2005 to 2016. Cureus [Internet]. 2020;12.
   Google Scholar
• Bedeschi MF, Bianchi V, Colli AM, et al. Clinical follow-up of young adults affected by Williams syndrome: experience of 45 Italian patients. Am J Med Genet Part A. 2011;155:353–359.
   Google Scholar
• Collins RT. Cardiovascular disease in Williams syndrome. Curr Opin Pediatr. 2018;30:609–615.
   PubMed Web of Science ®Google Scholar
• Cha SG, Song MK, Lee SY, et al. Long-term cardiovascular outcome of Williams syndrome. Congenit Heart Dis [Internet]. 2019;14:684–690.
   PubMed Web of Science ®Google Scholar
• Collins RT, Aziz PF, Gleason MM, et al. Abnormalities of cardiac repolarization in Williams syndrome. Am J Cardiol. 2010;106:1029–1033.
   PubMed Web of Science ®Google Scholar
• Broder K, Reinhardt E, Ahern J, et al. Elevated ambulatory blood pressure in 20 subjects with Williams syndrome. Am J Med Genet. 1999;83:356–360.
   PubMed Web of Science ®Google Scholar
• Giordano U, Turchetta A, Giannotti A, et al. Exercise testing and 24-hour ambulatory blood pressure monitoring in children with Williams syndrome. Pediatr Cardiol. 2001;22:509–511.
   PubMed Web of Science ®Google Scholar
• Lunati ME, Bedeschi MF, Resi V, et al. Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study. PLoS One. 2017;12:e0185371.
   PubMed Web of Science ®Google Scholar
• Masserini B, Bedeschi MF, Bianchi V, et al. Prevalence of diabetes and pre-diabetes in a cohort of Italian young adults with Williams syndrome. Am J Med Genet Part A. 2013;161:817–821.
   Google Scholar
• Pober BR, Wang E, Caprio S, et al. High prevalence of diabetes and pre-diabetes in adults with Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154:291–298.
   Google Scholar
• Sindhar S, Lugo M, Levin MD, et al. Hypercalcemia in patients with Williams-Beuren syndrome. J Pediatr. 2016;178:254–260.e4.
   PubMed Web of Science ®Google Scholar
• Stagi S, Bindi G, Neri AS, et al. Thyroid function and morphology in patients affected by Williams syndrome. Clin Endocrinol. 2005;63:456–460.
   PubMed Web of Science ®Google Scholar
• Tang R, Wang J, Yang L, et al. Subclinical hypothyroidism and depression: a systematic review and meta-analysis. Front Endocrinol. 2019;10.
   Web of Science ®Google Scholar
• Shaikh S, Waxler JL, Lee H, et al. Glucose and lipid metabolism, bone density, and body composition in individuals with Williams syndrome. Clin Endocrinol. 2018;89:596–604.
   PubMed Web of Science ®Google Scholar
• Cherniske EM, Carpenter TO, Klaiman C, et al. Multisystem study of 20 older adults with Williams syndrome.. Am J Med Genet. 2004;131A:255–264.
   Web of Science ®Google Scholar
• Copes LE, Pober BR, Terilli CA. Description of common musculoskeletal findings in Williams Syndrome and implications for therapies. Clin. Anat. 2016;29:578–589.
   PubMed Web of Science ®Google Scholar
• Gagliardi C, Martelli S, Burt MD, et al. Evolution of neurologic features in Williams syndrome. Pediatr Neurol. 2007;36:301–306.
   PubMed Web of Science ®Google Scholar
• Barozzi S, Soi D, Gagliardi C, et al. Balance function in patients with Williams syndrome. Gait Posture. 2013;38:221–225.
   PubMed Web of Science ®Google Scholar
• Devenny DA, Krinsky-McHale SJ, Kittler PM, et al. Age-associated memory changes in adults with Williams syndrome. Dev Neuropsychol. 2004;26:691–706.
   PubMed Web of Science ®Google Scholar
• Sauna-Aho O, Bjelogrlic-Laakso N, Siren A, et al. Signs indicating dementia in Down, Williams and Fragile X syndromes. Mol Genet Genomic Med. 2018;6:855–860.
   PubMed Web of Science ®Google Scholar
• Sammour ZM, de Bessa J, Hisano M, et al. Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome. J Pediatr Urol. 2017;13:203.e1–203.e6.
   PubMed Web of Science ®Google Scholar
• Gothelf D, Farber N, Raveh E, et al. Hyperacusis in Williams syndrome: characteristics and associated neuroaudiologic abnormalities. Neurology. 2006;66:390–395.
   PubMed Web of Science ®Google Scholar
• Stinton C, Elison S, Howlin P. Mental health problems in adults with Williams syndrome. Am J Intellect Dev Disabil. 2010;115:3–18.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
   Google Scholar
• Klein-Tasman BP, Lee K. Problem behaviour and psychosocial functioning in young children with Williams syndrome: parent and teacher perspectives. J Intellect Disabil Res. 2017;61:853–865.
   PubMed Web of Science ®Google Scholar
• Rhodes SM, Riby DM, Matthews K, et al. Attention-deficit/hyperactivity disorder and Williams syndrome: shared behavioral and neuropsychological profiles. J Clin Exp Neuropsychol. 2011;33:147–156.
   PubMed Web of Science ®Google Scholar
• Davies M, Udwin O, Howlin P. Adults with Williams syndrome: preliminary study of social, emotional and behavioural difficulties. Br J Psychiatry. 1998;172:273–276.
   PubMed Web of Science ®Google Scholar
• Bawden HN, MacDonald GW, Shea S. Treatment of children with Williams syndrome with methylphenidate. J Child Neurol. 1997;12:248–252.
   PubMed Web of Science ®Google Scholar
• Power TJ, Blum NJ, Jones SM, et al. Brief report: response to methylphenidate in two children with Williams syndrome. J Autism Dev Disord. 1997;27:79–87.
   PubMed Web of Science ®Google Scholar
• Clark B, Bélanger S. ADHD in children and youth: <V>Part 3-Assessment and treatment with comorbid ASD, ID, or prematurity. Paediatr Child Health [Internet]. 2018;23.
   PubMed Web of Science ®Google Scholar
• Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894–921.
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Hagan JF, Allan C. et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics [Internet]. 2019;144.
   Google Scholar
• Feldman ME, Charach A, Bélanger SA. ADHD in children and youth: part 2—Treatment. Paediatr Child Health. 2018;23:462.
   PubMed Web of Science ®Google Scholar
• Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266–1274.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40:180–187.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden death: what is a physician to do? Pediatrics. 2006;118:1215–1219.
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Hanevold C. Evaluation and management of elevated blood pressure in children and adolescents with attention deficit hyperactivity disorder. Curr Hypertens Rep. 2019;21:60.
   PubMed Web of Science ®Google Scholar
• Schatzberg A, DeBattista C. Manual of Clinical Psychopharmacology. 8th ed. Arlington, VA: American Psychiatric Publishing, Inc; 2015.
   Google Scholar
• Goldman SE, Malow BA, Newman KD, et al. Sleep patterns and daytime sleepiness in adolescents and young adults with Williams syndrome. J Intellect Disabil Res. 2009;53:182–188.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Correll CU. Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiatry. 2014;53:174–187.
   PubMed Web of Science ®Google Scholar
• Levine K, Wharton R. Williams syndrome and happiness. Am J Ment Retard. 2000;105(5):363.
   PubMedGoogle Scholar
• Royston R, Howlin P, Waite J, et al. Anxiety disorders in Williams syndrome contrasted with intellectual disability and the general population: a systematic review and meta-analysis. J Autism Dev Disord. 2017;47:3765–3777.
   PubMed Web of Science ®Google Scholar
• Dodd HF, Schniering CA, Porter MA. Beyond behaviour: is social anxiety low in Williams syndrome? J Autism Dev Disord. 2009;39:1673–1681.
   PubMed Web of Science ®Google Scholar
• Woodruff-Borden J, Kistler DJ, Henderson DR, et al. Longitudinal course of anxiety in children and adolescents with Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:277–290.
   PubMed Web of Science ®Google Scholar
• Ng-Cordell E, Hanley M, Kelly A, et al. Anxiety in Williams syndrome: the role of social behaviour, executive functions and change over time. J Autism Dev Disord [Internet]. 2018;48:796–808.
   PubMed Web of Science ®Google Scholar
• Cherniske EM, Carpenter TO, Klaiman C, et al. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet A. 2004;131:255–264.
   PubMed Web of Science ®Google Scholar
• Riby DM, Hanley M, Kirk H, et al. The interplay between anxiety and social functioning in Williams syndrome. J Autism Dev Disord. 2014;44:1220–1229.
   PubMed Web of Science ®Google Scholar
• Pitts CH, Klein-Tasman BP, Osborne JW, et al. Predictors of specific phobia in children with Williams syndrome. J Intellect Disabil Res. 2016;60:1031–1042.
   PubMed Web of Science ®Google Scholar
• McDougle C, Kresch L, Posey D. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors. J Autism Dev Disord. 2000;30:427–435.
   PubMed Web of Science ®Google Scholar
• Burcu M, Zito JM, Safer DJ, et al. Association of antidepressant medications with incident type 2 diabetes among medicaid-insured youths. JAMA Pediatr. 2017;171:1200–1207.
   PubMed Web of Science ®Google Scholar
• Beach SR, Celano CM, Sugrue AM, et al. QT prolongation, Torsades de Pointes, and psychotropic medications: A 5-year update. Psychosomatics. 2018;59:105–122.
   PubMed Web of Science ®Google Scholar
• Kumar M, Bajpai R, Shaik AR, et al. Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis. Eur J Clin Pharmacol. 2020.
   PubMed Web of Science ®Google Scholar
• Ducy P, Karsenty G. The two faces of serotonin in bone biology [Internet]. J Cell Biol. 2010;191:7–13.
   PubMed Web of Science ®Google Scholar
• Wang CY, Fu SH, Wang CL, et al. Serotonergic antidepressant use and the risk of fracture: a population-based nested case–control study. Osteoporos Int. 2016;27:57–63.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wang L, Wen X, et al. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat. 2017;13:2781–2796.
   PubMed Web of Science ®Google Scholar
• Thom RP, Keary CJ, Waxler JL, et al. Buspirone for the treatment of generalized anxiety disorder in Williams syndrome: A case series. J Autism Dev Disord [Internet]. 2020;50:676–682.
   PubMed Web of Science ®Google Scholar
• Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2010;CD006815. DOI:10.1002/14651858.CD006815.pub2
   PubMed Web of Science ®Google Scholar
• Pariente A, de Gage SB, Moore N, et al. The benzodiazepine-dementia disorders link: current state of knowledge. CNS Drugs. 2016;30:1–7.
   PubMed Web of Science ®Google Scholar
• Gwilliam K, Joyce A, Dimitriou D. Early manifestation of sleep problems in toddlers with Williams Syndrome using a mixed method longitudinal approach. Res Dev Disabil. 2020;104:103658.
   PubMed Web of Science ®Google Scholar
• Axelsson EL, Hill CM, Sadeh A, et al. Sleep problems and language development in toddlers with Williams syndrome. Res Dev Disabil. 2013;34:3988–3996.
   PubMed Web of Science ®Google Scholar
• Mason TBA, Arens R, Sharman J, et al. Sleep in children with Williams Syndrome. Sleep Med [Internet]. 2011;12:892–897.
   PubMed Web of Science ®Google Scholar
• Bódizs R, Gombos F, Gerván P, et al. Aging and sleep in Williams syndrome: accelerated sleep deterioration and decelerated slow wave sleep decrement. Res Dev Disabil [Internet]. 2014;35:3226–3235.
   PubMed Web of Science ®Google Scholar
• Martens MA, Seyfer DL, Andridge RR, et al. Use and effectiveness of sleep medications by parent report in individuals with Williams syndrome. J Dev Behav Pediatr. 2017;38:765–771.
   PubMed Web of Science ®Google Scholar
• Arens R, Wright B, Elliott J, et al. Periodic limb movement in sleep in children with Williams syndrome. J Pediatr . 1998;133:670–674.
   PubMed Web of Science ®Google Scholar
• Besag FMC, Vasey MJ, Lao KSJ, et al. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: A systematic review. CNS Drugs. 2019;1167–1186.
   PubMed Web of Science ®Google Scholar
• Stinton C, Tomlinson K, Estes Z. Examining reports of mental health in adults with Williams syndrome. Res Dev Disabil. 2012;33:144–152.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Sampson NA, Berglund P, et al. Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys. Epidemiol Psychiatr Sci. 2015;24:210–226.
   PubMed Web of Science ®Google Scholar
• Valdes F, Keary CJ, Mullett JE, et al. Major depressive disorder with psychotic features in Williams Syndrome: A case series. J Autism Dev Disord [Internet]. 2018;48:947–952.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological Treatments [Internet]. Can J Psychiatry. 2016;61(9):540–560.
   PubMed Web of Science ®Google Scholar
• Ansari A, Osser D. Psychopharmacology: A concise overview for students and clinicians. 2nd ed ed. North Charleston, SC: CreateSpace Independent Publishing; 2015.
   Google Scholar
• Castro V, Clements C, Murphy S, et al. QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ. 2013;346:f288.
   PubMed Web of Science ®Google Scholar
• Pineiro ML, Roberts AM, Waxler JL, et al. N-acetylcysteine for neuropsychiatric symptoms in a woman with Williams syndrome. J Child Neurol. 2014;29:NP135–NP138.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.
   PubMed Web of Science ®Google Scholar
• Guy W, editor. Abnormal Involuntary Movement Scale (117‐AIMS). ECDEU Assess Man Psychopharmacol. Rockville, MD: National Institute of Mental Health; 1976. p. 534–537.
   Google Scholar
• Gitlin M. Lithium side effects and toxicity: prevalence and management strategies [Internet]. Int J Bipolar Disord. 2016;27.
   Google Scholar
• Azab AN, Shnaider A, Osher Y. et al. Lithium nephrotoxicity. Int J Bipolar Disord [Internet]. 2015;3.
   Google Scholar
• Salgado H, Martins-Correia L. Williams syndrome and psychosis: A case report. J Med Case Rep. 2014;8:8.
   PubMedGoogle Scholar
• Lieberman JA, Scott Stroup T, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–1223.
   PubMed Web of Science ®Google Scholar
• Savoja V, Vicari S. Development of erosive gastrointestinal lesions during risperidone treatment in two patients with Williams syndrome [Internet]. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:711–712.
   PubMed Web of Science ®Google Scholar
• Dayabandara M, Hanwella R, Ratnatunga S, et al. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat. 2017;Volume 13:2231–2241.
   Web of Science ®Google Scholar